2015-10-30 | Reiterated Rating | FBR & Co. | Marketperform | |
2014-03-31 | Downgrade | HC Wainwright | Buy to Neutral | $33.00 to $5.00 |
2014-03-31 | Downgrade | MLV & Co. | Buy to Hold | $11.00 to $3.00 |
2014-02-26 | Boost Price Target | HC Wainwright | $20.50 to $33.00 | |
2014-02-18 | Initiated Coverage | HC Wainwright | Buy | $20.50 |
2012-12-20 | Initiated | Burrill Institutional Research | Mkt Outperform | $5 |
2011-10-04 | Initiated | MLV Capital | Buy | $6 |
2008-09-09 | Upgrade | Rodman & Renshaw | Mkt Perform to Mkt Outperform | $8 |
1970-01-01 |
2015-10-30 | Reiterated Rating | FBR & Co. | Marketperform | |
2014-03-31 | Downgrade | HC Wainwright | Buy to Neutral | $33.00 to $5.00 |
2014-03-31 | Downgrade | MLV & Co. | Buy to Hold | $11.00 to $3.00 |
2014-02-26 | Boost Price Target | HC Wainwright | $20.50 to $33.00 | |
2014-02-18 | Initiated Coverage | HC Wainwright | Buy | $20.50 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In PRAN 1 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
MetLife Securities, Inc | 500 |